Loading provider…
Loading provider…
Medical Oncology Physician in Fargo, ND
NPI: 1225073661Primary Practice Location
SANFORD MEDICAL CENTER FARGO
801 Broadway N, Fargo, ND
Primary Employer
Sanford Medical Center - Cavalier
sanfordhealth.org
HQ Phone
Get M.D. Mark's Phone Numberphone_androidMobile
Get M.D. Mark's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMN State Medical License
ND State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 171 | 317 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 51 | 74 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 21 | 24 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 20 | 20 |
Authors: Kevin Palka, Omar Atiq, Steven Powell, William Spanos, Caron Rigden, Peter Oppelt
Journal: Oral Oncol
Publication Date: 2021-02-03
Implementation of a standardized approach to borderline resectable pancreatic cancer in a multisite community oncology program.
Authors: Daniel Tuvin, Ryan Nowak, Gary Timmerman, Miran Blanchard, Robert Sticca, Miroslaw Mazurczak, Peter Kurniali, Christopher Sumey, Steven Powell, Michele Lohr, Jonathan Bleeker, Preston Steen
Publication Date: 2019-12-08
Authors: Ryan Jackson, Kevin Palka, Hiram Gay, Mackenzie Daly, Jason Rich, Wade Thorstad, Steven Powell, William Spanos, Patrik Pipkorn, Randal Paniello, Peter Oppelt
Journal: Med Oncol
Publication Date: 2021-03-08
Lead Sponsor: Washington University School of Medicine
Collaborators: Celgene Corporation
Intervention / Treatment: DRUG: Carboplatin, BIOLOGICAL: Cetuximab, DRUG: Cisplatin, DRUG: nab-paclitaxel
Lead Sponsor: Sanford Health
Collaborators: Merck Sharp & Dohme LLC
Intervention / Treatment: DRUG: Cisplatin, RADIATION: Radiation, DRUG: pembrolizumab (MK-3475)